yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34652175-3C72A0DB-7570-438B-8B7E-6EAA75FC319E
Q34652175-3C72A0DB-7570-438B-8B7E-6EAA75FC319E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34652175-3C72A0DB-7570-438B-8B7E-6EAA75FC319E
The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.
P2860
Q34652175-3C72A0DB-7570-438B-8B7E-6EAA75FC319E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34652175-3C72A0DB-7570-438B-8B7E-6EAA75FC319E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54667815d9771d23ab3580684fd39af3b96c06eb
P2860
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy